SLCO2B1 and hepatocellular carcinoma: Using UALCAN, we analyzed the SLCO2B1 transcript expression level in the normal liver tissues from healthy individuals and cancer liver tissues in HCC patients from different subgroups classified by gender, N stage, disease stage, and disease grade.